
Reset all filters
01 4Nilemdo/Nustendi
Bempedoic Acid, Ezetimibe, Bempedoic Acid
Bempedoic Acid, Ezetimibe, Bempedoic Acid
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2021 Revenue in Millions : 22
2020 Revenue in Millions : 0
Growth (%) : 100
Bempedoic Acid, Ezetimibe, Bempedoic Acid
Bempedoic Acid, Ezetimibe, Bempedoic Acid
Main Therapeutic Indication : Cardiology/Vascular Diseases
Currency : USD
2022 Revenue in Millions : 45
2021 Revenue in Millions : 22
Growth (%) : 103
Bempedoic Acid, Ezetimibe, Bempedoic Acid
Bempedoic Acid, Ezetimibe, Bempedoic Acid
Main Therapeutic Indication : Cardiology/Vascular Diseases
Currency : USD
2023 Revenue in Millions : 97
2022 Revenue in Millions : 45
Growth (%) : 147
Bempedoic Acid, Ezetimibe, Bempedoic Acid
Bempedoic Acid, Ezetimibe, Bempedoic Acid
Main Therapeutic Indication : Cardiology/Vascular Diseases
Currency : USD
2024 Revenue in Millions : 222
2023 Revenue in Millions : 96
Growth (%) : 131